Loading...
ASTH logo

Astrana Health, Inc.NasdaqCM:ASTH Stock Report

Market Cap US$1.4b
Share Price
US$27.41
US$36
23.9% undervalued intrinsic discount
1Y-14.2%
7D11.8%
Portfolio Value
View

Astrana Health, Inc.

NasdaqCM:ASTH Stock Report

Market Cap: US$1.4b

ASTH Community Fair Values

Create Narrative

See what 12 others think this stock is worth. Follow their fair value or set your own to get alerts.

Astrana Health, Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Astrana Health
Historical stock prices
Current Share PriceUS$27.41
52 Week HighUS$34.80
52 Week LowUS$18.08
Beta0.77
1 Month Change10.88%
3 Month Change-2.87%
1 Year Change-14.16%
3 Year Change-29.48%
5 Year Change1.29%
Change since IPO152.86%

Recent News & Updates

Astrana Health: A Delegated Risk Model At A Discount

Apr 08

Recent updates

Astrana Health: A Delegated Risk Model At A Discount

Apr 08

Is Astrana Health (NASDAQ:ASTH) Using Too Much Debt?

Nov 01
Is Astrana Health (NASDAQ:ASTH) Using Too Much Debt?

Astrana Health, Inc. (NASDAQ:ASTH) Not Lagging Market On Growth Or Pricing

Jun 25
Astrana Health, Inc. (NASDAQ:ASTH) Not Lagging Market On Growth Or Pricing

Astrana Health, Inc. (NASDAQ:ASTH) Stocks Shoot Up 29% But Its P/E Still Looks Reasonable

Feb 12
Astrana Health, Inc. (NASDAQ:ASTH) Stocks Shoot Up 29% But Its P/E Still Looks Reasonable

Calculating The Intrinsic Value Of Astrana Health, Inc. (NASDAQ:ASTH)

Jan 12
Calculating The Intrinsic Value Of Astrana Health, Inc. (NASDAQ:ASTH)

Here's Why Astrana Health (NASDAQ:ASTH) Can Manage Its Debt Responsibly

Dec 27
Here's Why Astrana Health (NASDAQ:ASTH) Can Manage Its Debt Responsibly

Is Now An Opportune Moment To Examine Astrana Health, Inc. (NASDAQ:ASTH)?

Dec 12
Is Now An Opportune Moment To Examine Astrana Health, Inc. (NASDAQ:ASTH)?

Impressive Earnings May Not Tell The Whole Story For Astrana Health (NASDAQ:ASTH)

Nov 22
Impressive Earnings May Not Tell The Whole Story For Astrana Health (NASDAQ:ASTH)

Astrana Health, Inc.'s (NASDAQ:ASTH) 33% Cheaper Price Remains In Tune With Earnings

Nov 18
Astrana Health, Inc.'s (NASDAQ:ASTH) 33% Cheaper Price Remains In Tune With Earnings

Here's What Analysts Are Forecasting For Astrana Health, Inc. (NASDAQ:ASTH) After Its Third-Quarter Results

Nov 10
Here's What Analysts Are Forecasting For Astrana Health, Inc. (NASDAQ:ASTH) After Its Third-Quarter Results

Astrana Health, Inc.'s (NASDAQ:ASTH) P/E Is Still On The Mark Following 25% Share Price Bounce

Oct 04
Astrana Health, Inc.'s (NASDAQ:ASTH) P/E Is Still On The Mark Following 25% Share Price Bounce

Is Astrana Health, Inc. (NASDAQ:ASTH) Trading At A 21% Discount?

Sep 26
Is Astrana Health, Inc. (NASDAQ:ASTH) Trading At A 21% Discount?

Astrana Health's (NASDAQ:ASTH) Returns On Capital Not Reflecting Well On The Business

Sep 12
Astrana Health's (NASDAQ:ASTH) Returns On Capital Not Reflecting Well On The Business
User avatar

Transitioning To Full-Risk Contracts Fuels Revenue Growth And Expands Healthcare Leadership

Transitioning to full-risk arrangements and technological investments aims to boost net margins by aligning costs with reimbursements and enhancing healthcare delivery.

Is Astrana Health (NASDAQ:ASTH) Using Too Much Debt?

Aug 28
Is Astrana Health (NASDAQ:ASTH) Using Too Much Debt?

Astrana Health, Inc.'s (NASDAQ:ASTH) 29% Jump Shows Its Popularity With Investors

Aug 02
Astrana Health, Inc.'s (NASDAQ:ASTH) 29% Jump Shows Its Popularity With Investors

Is There Now An Opportunity In Astrana Health, Inc. (NASDAQ:ASTH)?

Jun 19
Is There Now An Opportunity In Astrana Health, Inc. (NASDAQ:ASTH)?

Capital Allocation Trends At Astrana Health (NASDAQ:ASTH) Aren't Ideal

Jun 02
Capital Allocation Trends At Astrana Health (NASDAQ:ASTH) Aren't Ideal

Astrana Health, Inc. (NASDAQ:ASTH) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year

May 09
Astrana Health, Inc. (NASDAQ:ASTH) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Investors Still Waiting For A Pull Back In Astrana Health, Inc. (NASDAQ:ASTH)

Apr 15
Investors Still Waiting For A Pull Back In Astrana Health, Inc. (NASDAQ:ASTH)

Shareholder Returns

ASTHUS HealthcareUS Market
7D11.8%7.3%3.0%
1Y-14.2%-24.9%25.7%

Return vs Industry: ASTH exceeded the US Healthcare industry which returned -21.8% over the past year.

Return vs Market: ASTH underperformed the US Market which returned 32.8% over the past year.

Price Volatility

Is ASTH's price volatile compared to industry and market?
ASTH volatility
ASTH Average Weekly Movement12.9%
Healthcare Industry Average Movement7.5%
Market Average Movement7.1%
10% most volatile stocks in US Market16.1%
10% least volatile stocks in US Market3.3%

Stable Share Price: ASTH's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: ASTH's weekly volatility (13%) has been stable over the past year, but is still higher than 75% of US stocks.

About the Company

FoundedEmployeesCEOWebsite
19923,000Brandon Simwww.astranahealth.com

Astrana Health, Inc., a healthcare management company, provides medical care services in the United States. The company operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.

Astrana Health, Inc. Fundamentals Summary

How do Astrana Health's earnings and revenue compare to its market cap?
ASTH fundamental statistics
Market capUS$1.37b
Earnings (TTM)US$22.49m
Revenue (TTM)US$3.18b
60.3x
P/E Ratio
0.4x
P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
ASTH income statement (TTM)
RevenueUS$3.18b
Cost of RevenueUS$2.84b
Gross ProfitUS$341.53m
Other ExpensesUS$319.04m
EarningsUS$22.49m

Last Reported Earnings

Dec 31, 2025

Next Earnings Date

n/a

Earnings per share (EPS)0.45
Gross Margin10.73%
Net Profit Margin0.71%
Debt/Equity Ratio186.0%

How did ASTH perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/04/08 06:09
End of Day Share Price 2026/04/08 00:00
Earnings2025/12/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Astrana Health, Inc. is covered by 14 analysts. 10 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Hua HaBaird
Andrew MokBarclays
Sarah JamesBarclays